Cox, Melissa L.
Evans, Jacquelyn M.
Davis, Alexander G.
Guo, Ling T.
Levy, Jennifer R.
Starr-Moss, Alison N.
Salmela, Elina
Hytönen, Marjo K.
Lohi, Hannes
Campbell, Kevin P.
Clark, Leigh Anne
Shelton, G. Diane
Funding for this research was provided by:
National Institutes of Health (R13AR062868)
Wellstone Muscular Dystrophy Research Center (IU54S053672)
Article History
Received: 27 March 2017
Accepted: 23 June 2017
First Online: 11 July 2017
Ethics approval
: All dogs in this study were evaluated in a clinical veterinary practice by licensed veterinarians. The dogs in this study were examined and tissue biopsies collected with the written consent of their owners. Tissue studies were performed using protocols approved by the Institutional Animal Care and Use Committees (IACUC) of Clemson University, the University of California San Diego, and the University of Iowa, and the Animal Experiment Board in Finland (ESAVI/7482/04.10.07/2015), as well as the Baden-Württemberg veterinary office at the Landratsamt Tübingen Abt. 32: Veterinärwesen und Lebensmittelüberwachung, Tübingen, Germany (Registriernummer: DE 08 416 1038 21).
: Not applicable
: MC is employed by CAG GmbH that performs canine DNA testing on a commercial basis. HL is a co-founder of Genoscoper Laboratories Oy that offers canine DNA testing on a commercial basis. All other authors declare that they have no competing interests.